SRS Capital Advisors Inc. Grows Stock Holdings in Aflac Incorporated (NYSE:AFL)

SRS Capital Advisors Inc. increased its stake in shares of Aflac Incorporated (NYSE:AFL) by 351.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 460 shares of the financial services provider’s stock after purchasing an additional 358 shares during the period. SRS Capital Advisors Inc.’s holdings in Aflac were worth $48,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently made changes to their positions in the company. Whipplewood Advisors LLC purchased a new position in shares of Aflac during the fourth quarter valued at approximately $26,000. Darwin Wealth Management LLC purchased a new position in shares of Aflac during the third quarter valued at approximately $34,000. BankPlus Trust Department purchased a new position in shares of Aflac during the fourth quarter valued at approximately $34,000. Raelipskie Partnership purchased a new position in shares of Aflac during the third quarter valued at approximately $38,000. Finally, Covestor Ltd raised its holdings in shares of Aflac by 41.8% during the third quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock valued at $41,000 after purchasing an additional 107 shares during the last quarter. 67.44% of the stock is owned by hedge funds and other institutional investors.

Aflac Stock Performance

AFL opened at $108.48 on Friday. The firm has a market cap of $59.29 billion, a P/E ratio of 11.30, a PEG ratio of 3.24 and a beta of 0.93. Aflac Incorporated has a 1-year low of $79.31 and a 1-year high of $115.50. The company has a 50 day simple moving average of $105.08 and a two-hundred day simple moving average of $107.70. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.08.

Aflac (NYSE:AFL) last issued its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. Equities analysts forecast that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, EVP Audrey B. Tillman sold 24,744 shares of the company’s stock in a transaction on Friday, December 27th. The shares were sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the completion of the transaction, the executive vice president now owns 222,618 shares in the company, valued at approximately $23,018,701.20. This represents a 10.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.90% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

AFL has been the subject of a number of research reports. Morgan Stanley upped their target price on shares of Aflac from $98.00 to $105.00 and gave the company an “equal weight” rating in a report on Friday, February 28th. JPMorgan Chase & Co. upped their target price on shares of Aflac from $90.00 to $94.00 and gave the company a “neutral” rating in a report on Tuesday, January 7th. Keefe, Bruyette & Woods reduced their target price on shares of Aflac from $107.00 to $104.00 and set a “market perform” rating for the company in a report on Wednesday, February 12th. Piper Sandler reduced their target price on shares of Aflac from $122.00 to $118.00 and set an “overweight” rating for the company in a report on Friday, February 7th. Finally, Barclays reduced their target price on shares of Aflac from $98.00 to $95.00 and set an “underweight” rating for the company in a report on Friday, February 7th. Two equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $103.36.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.